Delivery Order SPE2DB22D3301-SPE2DB25FY2BV

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a firm fixed price of $15,369.89 and an ultimate completion date of September 5, 2024. The award is not associated with a set-aside program. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a ceiling value of $5,475.07 and a completion date of November 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 54 mg Concerta ER tablets. The delivery order has a ceiling value of $12,711.60 and a firm fixed price pricing type. It is not designated as a set-aside contract. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CONCERTA ER 27 MG TABLET 100S. The contract has a ceiling value of $12,037.03 and a period of performance ending on August 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Concerta ER 36 mg tablets. The total ceiling value of the contract is $4,347.28, and it is a firm fixed price delivery order with an ultimate completion date of October 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Concerta ER 27 mg tablets. The contract has a ceiling value of $1,709.72 and is a firm fixed price delivery order. The ultimate completion date is September 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4562869372 CONCERTA ER 27 MG TABLET 100S. The contract has a ceiling value of $13,926.35 and is a firm fixed price contract with a completion date of November 21, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CONCERTA ER 36 MG TABLET 100S. The firm fixed price contract, valued at $3,141.86, has an ultimate completion date of September 19, 2024. This award is not associated with a set-aside. As a large supplier of medical commodities to the federal government, Amerisourcebergen holds several Indefinite Delivery Contracts...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, the prime contractor. The contract is for the delivery of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. The contract has a ceiling value of $3,938.13 and a performance period through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CONCERTA ER 36 MG TABLET 100S, a prescription medication, with a ceiling value of $1,012.23 and a performance period through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2BV
    Delivery Order

This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a firm fixed price and a ceiling value of $3,399.44. It is not designated as a set-aside contract. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/29/25, 1:04 AM